Inquire Before Buying
Speak to an Analyst 
Request Brochure 
Request CustomizationIMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
Read More
Rat Model Market Report by Model Type (Outbred Rats, Inbred Rats, Knockout/Genetically Modified Rats, Hybrid/Congenic Rats, Conditioned/Surgically Modified Rats, Immunodeficient Rats), Technology (Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Microinjection, Embryonic Stem Cell Injection, Nuclear Transfer, and Others), Service (Breeding, Cryopreservation, Re-derivation, Genetic Testing, Quarantine, and Others), Therapeutic Area (Oncology, Neurology, Immunology, Toxicology, and Others), End User (Contract Research Organizations (CROs), Academic and Research Institutes, Pharmaceutical and Biotechnology Companies), and Region 2024-2032
Report Format: PDF+Excel | Report ID: SR112024A12751
Buy Now
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Global Rat Model Market - Introduction
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence
5 Global Rat Model Market Landscape
5.1 Historical and Current Market Trends (2018-2023)
5.2 Market Forecast (2024-2032)
6 Global Rat Model Market - Breakup by Model Type
6.1 Outbred Rats
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2018-2023)
6.1.3 Market Segmentation
6.1.4 Market Forecast (2024-2032)
6.2 Inbred Rats
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2018-2023)
6.2.3 Market Segmentation
6.2.4 Market Forecast (2024-2032)
6.3 Knockout/Genetically Modified Rats
6.3.1 Overview
6.3.2 Historical and Current Market Trends (2018-2023)
6.3.3 Market Segmentation
6.3.4 Market Forecast (2024-2032)
6.4 Hybrid/Congenic Rats
6.4.1 Overview
6.4.2 Historical and Current Market Trends (2018-2023)
6.4.3 Market Segmentation
6.4.4 Market Forecast (2024-2032)
6.5 Conditioned/Surgically Modified Rats
6.5.1 Overview
6.5.2 Historical and Current Market Trends (2018-2023)
6.5.3 Market Segmentation
6.5.4 Market Forecast (2024-2032)
6.6 Immunodeficient Rats
6.6.1 Overview
6.6.2 Historical and Current Market Trends (2018-2023)
6.6.3 Market Segmentation
6.6.4 Market Forecast (2024-2032)
6.7 Attractive Investment Proposition by Model Type
7 Global Rat Model Market - Breakup by Technology
7.1 Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2018-2023)
7.1.3 Market Segmentation
7.1.4 Market Forecast (2024-2032)
7.2 Microinjection
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2018-2023)
7.2.3 Market Segmentation
7.2.4 Market Forecast (2024-2032)
7.3 Embryonic Stem Cell Injection
7.3.1 Overview
7.3.2 Historical and Current Market Trends (2018-2023)
7.3.3 Market Segmentation
7.3.4 Market Forecast (2024-2032)
7.4 Nuclear Transfer
7.4.1 Overview
7.4.2 Historical and Current Market Trends (2018-2023)
7.4.3 Market Segmentation
7.4.4 Market Forecast (2024-2032)
7.5 Others
7.5.1 Historical and Current Market Trends (2018-2023)
7.5.2 Market Forecast (2024-2032)
7.6 Attractive Investment Proposition by Technology
8 Global Rat Model Market - Breakup by Service
8.1 Breeding
8.1.1 Overview
8.1.2 Historical and Current Market Trends (2018-2023)
8.1.3 Market Segmentation
8.1.4 Market Forecast (2024-2032)
8.2 Cryopreservation
8.2.1 Overview
8.2.2 Historical and Current Market Trends (2018-2023)
8.2.3 Market Segmentation
8.2.4 Market Forecast (2024-2032)
8.3 Re-derivation
8.3.1 Overview
8.3.2 Historical and Current Market Trends (2018-2023)
8.3.3 Market Segmentation
8.3.4 Market Forecast (2024-2032)
8.4 Genetic Testing
8.4.1 Overview
8.4.2 Historical and Current Market Trends (2018-2023)
8.4.3 Market Segmentation
8.4.4 Market Forecast (2024-2032)
8.5 Quarantine
8.5.1 Overview
8.5.2 Historical and Current Market Trends (2018-2023)
8.5.3 Market Segmentation
8.5.4 Market Forecast (2024-2032)
8.6 Others
8.6.1 Historical and Current Market Trends (2018-2023)
8.6.2 Market Forecast (2024-2032)
8.7 Attractive Investment Proposition by Service
9 Global Rat Model Market - Breakup by Therapeutic Area
9.1 Oncology
9.1.1 Overview
9.1.2 Historical and Current Market Trends (2018-2023)
9.1.3 Market Segmentation
9.1.4 Market Forecast (2024-2032)
9.2 Neurology
9.2.1 Overview
9.2.2 Historical and Current Market Trends (2018-2023)
9.2.3 Market Segmentation
9.2.4 Market Forecast (2024-2032)
9.3 Immunology
9.3.1 Overview
9.3.2 Historical and Current Market Trends (2018-2023)
9.3.3 Market Segmentation
9.3.4 Market Forecast (2024-2032)
9.4 Toxicology
9.4.1 Overview
9.4.2 Historical and Current Market Trends (2018-2023)
9.4.3 Market Segmentation
9.4.4 Market Forecast (2024-2032)
9.5 Others
9.5.1 Historical and Current Market Trends (2018-2023)
9.5.2 Market Forecast (2024-2032)
9.6 Attractive Investment Proposition by Therapeutic Area
10 Global Rat Model Market - Breakup by End User
10.1 Contract Research Organizations (CROs)
10.1.1 Overview
10.1.2 Historical and Current Market Trends (2018-2023)
10.1.3 Market Segmentation
10.1.4 Market Forecast (2024-2032)
10.2 Academic and Research Institutes
10.2.1 Overview
10.2.2 Historical and Current Market Trends (2018-2023)
10.2.3 Market Segmentation
10.2.4 Market Forecast (2024-2032)
10.3 Pharmaceutical and Biotechnology Companies
10.3.1 Overview
10.3.2 Historical and Current Market Trends (2018-2023)
10.3.3 Market Segmentation
10.3.4 Market Forecast (2024-2032)
10.4 Attractive Investment Proposition by End User
11 Global Rat Model Market – Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Drivers
11.1.1.2 Historical and Current Market Trends (2018-2023)
11.1.1.3 Market Breakup by Model Type
11.1.1.4 Market Breakup by Technology
11.1.1.5 Market Breakup by Service
11.1.1.6 Market Breakup by Therapeutic Area
11.1.1.7 Market Breakup by End User
11.1.1.8 Key Players
11.1.1.9 Market Forecast (2024-2032)
11.1.2 Canada
11.1.2.1 Market Drivers
11.1.2.2 Historical and Current Market Trends (2018-2023)
11.1.2.3 Market Breakup by Model Type
11.1.2.4 Market Breakup by Technology
11.1.2.5 Market Breakup by Service
11.1.2.6 Market Breakup by Therapeutic Area
11.1.2.7 Market Breakup by End User
11.1.2.8 Key Players
11.1.2.9 Market Forecast (2024-2032)
11.2 Europe
11.2.1 Germany
11.2.1.1 Market Drivers
11.2.1.2 Historical and Current Market Trends (2018-2023)
11.2.1.3 Market Breakup by Model Type
11.2.1.4 Market Breakup by Technology
11.2.1.5 Market Breakup by Service
11.2.1.6 Market Breakup by Therapeutic Area
11.2.1.7 Market Breakup by End User
11.2.1.8 Key Players
11.2.1.9 Market Forecast (2024-2032)
11.2.2 France
11.2.2.1 Market Drivers
11.2.2.2 Historical and Current Market Trends (2018-2023)
11.2.2.3 Market Breakup by Model Type
11.2.2.4 Market Breakup by Technology
11.2.2.5 Market Breakup by Service
11.2.2.6 Market Breakup by Therapeutic Area
11.2.2.7 Market Breakup by End User
11.2.2.8 Key Players
11.2.2.9 Market Forecast (2024-2032)
11.2.3 United Kingdom
11.2.3.1 Market Drivers
11.2.3.2 Historical and Current Market Trends (2018-2023)
11.2.3.3 Market Breakup by Model Type
11.2.3.4 Market Breakup by Technology
11.2.3.5 Market Breakup by Service
11.2.3.6 Market Breakup by Therapeutic Area
11.2.3.7 Market Breakup by End User
11.2.3.8 Key Players
11.2.3.9 Market Forecast (2024-2032)
11.2.4 Italy
11.2.4.1 Market Drivers
11.2.4.2 Historical and Current Market Trends (2018-2023)
11.2.4.3 Market Breakup by Model Type
11.2.4.4 Market Breakup by Technology
11.2.4.5 Market Breakup by Service
11.2.4.6 Market Breakup by Therapeutic Area
11.2.4.7 Market Breakup by End User
11.2.4.8 Key Players
11.2.4.9 Market Forecast (2024-2032)
11.2.5 Spain
11.2.5.1 Market Drivers
11.2.5.2 Historical and Current Market Trends (2018-2023)
11.2.5.3 Market Breakup by Model Type
11.2.5.4 Market Breakup by Technology
11.2.5.5 Market Breakup by Service
11.2.5.6 Market Breakup by Therapeutic Area
11.2.5.7 Market Breakup by End User
11.2.5.8 Key Players
11.2.5.9 Market Forecast (2024-2032)
11.2.6 Others
11.2.6.1 Historical and Current Market Trends (2018-2023)
11.2.6.2 Market Forecast (2024-2032)
11.3 Asia Pacific
11.3.1 China
11.3.1.1 Market Drivers
11.3.1.2 Historical and Current Market Trends (2018-2023)
11.3.1.3 Market Breakup by Model Type
11.3.1.4 Market Breakup by Technology
11.3.1.5 Market Breakup by Service
11.3.1.6 Market Breakup by Therapeutic Area
11.3.1.7 Market Breakup by End User
11.3.1.8 Key Players
11.3.1.9 Market Forecast (2024-2032)
11.3.2 Japan
11.3.2.1 Market Drivers
11.3.2.2 Historical and Current Market Trends (2018-2023)
11.3.2.3 Market Breakup by Model Type
11.3.2.4 Market Breakup by Technology
11.3.2.5 Market Breakup by Service
11.3.2.6 Market Breakup by Therapeutic Area
11.3.2.7 Market Breakup by End User
11.3.2.8 Key Players
11.3.2.9 Market Forecast (2024-2032)
11.3.3 India
11.3.3.1 Market Drivers
11.3.3.2 Historical and Current Market Trends (2018-2023)
11.3.3.3 Market Breakup by Model Type
11.3.3.4 Market Breakup by Technology
11.3.3.5 Market Breakup by Service
11.3.3.6 Market Breakup by Therapeutic Area
11.3.3.7 Market Breakup by End User
11.3.3.8 Key Players
11.3.3.9 Market Forecast (2024-2032)
11.3.4 South Korea
11.3.4.1 Market Drivers
11.3.4.2 Historical and Current Market Trends (2018-2023)
11.3.4.3 Market Breakup by Model Type
11.3.4.4 Market Breakup by Technology
11.3.4.5 Market Breakup by Service
11.3.4.6 Market Breakup by Therapeutic Area
11.3.4.7 Market Breakup by End User
11.3.4.8 Key Players
11.3.4.9 Market Forecast (2024-2032)
11.3.5 Australia
11.3.5.1 Market Drivers
11.3.5.2 Historical and Current Market Trends (2018-2023)
11.3.5.3 Market Breakup by Model Type
11.3.5.4 Market Breakup by Technology
11.3.5.5 Market Breakup by Service
11.3.5.6 Market Breakup by Therapeutic Area
11.3.5.7 Market Breakup by End User
11.3.5.8 Key Players
11.3.5.9 Market Forecast (2024-2032)
11.3.6 Indonesia
11.3.6.1 Market Drivers
11.3.6.2 Historical and Current Market Trends (2018-2023)
11.3.6.3 Market Breakup by Model Type
11.3.6.4 Market Breakup by Technology
11.3.6.5 Market Breakup by Service
11.3.6.6 Market Breakup by Therapeutic Area
11.3.6.7 Market Breakup by End User
11.3.6.8 Key Players
11.3.6.9 Market Forecast (2024-2032)
11.3.7 Others
11.3.7.1 Historical and Current Market Trends (2018-2023)
11.3.7.2 Market Forecast (2024-2032)
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Drivers
11.4.1.2 Historical and Current Market Trends (2018-2023)
11.4.1.3 Market Breakup by Model Type
11.4.1.4 Market Breakup by Technology
11.4.1.5 Market Breakup by Service
11.4.1.6 Market Breakup by Therapeutic Area
11.4.1.7 Market Breakup by End User
11.4.1.8 Key Players
11.4.1.9 Market Forecast (2024-2032)
11.4.2 Mexico
11.4.2.1 Market Drivers
11.4.2.2 Historical and Current Market Trends (2018-2023)
11.4.2.3 Market Breakup by Model Type
11.4.2.4 Market Breakup by Technology
11.4.2.5 Market Breakup by Service
11.4.2.6 Market Breakup by Therapeutic Area
11.4.2.7 Market Breakup by End User
11.4.2.8 Key Players
11.4.2.9 Market Forecast (2024-2032)
11.4.3 Others
11.4.3.1 Historical and Current Market Trends (2018-2023)
11.4.3.2 Market Forecast (2024-2032)
11.5 Middle East and Africa
11.5.1.1 Market Drivers
11.5.1.2 Historical and Current Market Trends (2018-2023)
11.5.1.3 Market Breakup by Model Type
11.5.1.4 Market Breakup by Technology
11.5.1.5 Market Breakup by Service
11.5.1.6 Market Breakup by Therapeutic Area
11.5.1.7 Market Breakup by End User
11.5.1.8 Market Breakup by Country
11.5.1.9 Key Players
11.5.1.10 Market Forecast (2024-2032)
11.6 Attractive Investment Proposition by Region
12 Global Rat Model Market – Competitive Landscape
12.1 Overview
12.2 Market Structure
12.3 Market Share by Key Players
12.4 Market Player Positioning
12.5 Top Winning Strategies
12.6 Competitive Dashboard
12.7 Company Evaluation Quadrant
13 Profiles of Key Players
13.1 Biomere
13.1.1 Business Overview
13.1.2 Product Portfolio
13.1.3 Business Strategies
13.1.4 SWOT Analysis
13.1.5 Major News and Events
13.2 Charles River Laboratories International Inc.
13.2.1 Business Overview
13.2.2 Product Portfolio
13.2.3 Business Strategies
13.2.4 Financials
13.2.5 SWOT Analysis
13.2.6 Major News and Events
13.3 Cyagen Biosciences Inc.
13.3.1 Business Overview
13.3.2 Product Portfolio
13.3.3 Business Strategies
13.3.5 SWOT Analysis
13.3.6 Major News and Events
13.4 Envigo (Inotiv Inc.)
13.4.1 Business Overview
13.4.2 Product Portfolio
13.4.3 Business Strategies
13.4.4 SWOT Analysis
13.4.5 Major News and Events
13.5 genOway S.A.
13.5.1 Business Overview
13.5.2 Product Portfolio
13.5.3 Business Strategies
13.5.4 Financials
13.5.5 SWOT Analysis
13.5.6 Major News and Events
13.6 Janvier Labs
13.6.1 Business Overview
13.6.2 Product Portfolio
13.6.3 Business Strategies
13.6.4 SWOT Analysis
13.6.5 Major News and Events
13.7 Taconic Biosciences Inc.
13.7.1 Business Overview
13.7.2 Product Portfolio
13.7.3 Business Strategies
13.7.4 SWOT Analysis
13.7.5 Major News and Events
13.8 TransViragen Inc.
13.8.1 Business Overview
13.8.2 Product Portfolio
13.8.3 Business Strategies
13.8.4 SWOT Analysis
13.8.5 Major News and Events
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
14 Global Rat Model Market - Industry Analysis
14.1 Drivers, Restraints, and Opportunities
14.1.1 Overview
14.1.2 Drivers
14.1.3 Restraints
14.1.4 Opportunities
14.1.5 Impact Analysis
14.2 Porters Five Forces Analysis
14.2.1 Overview
14.2.2 Bargaining Power of Buyers
14.2.3 Bargaining Power of Suppliers
14.2.4 Degree of Competition
14.2.5 Threat of New Entrants
14.2.6 Threat of Substitutes
14.3 Value Chain Analysis
15 Strategic Recommendations
16 Appendix
Benefits of Customization
Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-631-791-1145
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-714-6104
Email: sales@imarcgroup.com
Client Testimonials
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
Read More
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
Read More
Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.
Read More.webp)
We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.
Read More
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
Read More
The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.
Read More
My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.
Read More
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
Read More.webp){kind=logo}
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.
Read More
IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.
Read More
IMARC did an outstanding job in preparing our study. They were punctual and precise, delivering all the data we required in a clear and well-organized format. Their attention to detail and ability to meet deadlines was impressive, making them a reliable partner for our project.
Read More
I wanted to express my sincere appreciation for your efforts in handling this matter. Your dedication and commitment have truly been commendable. It is evident that you have put in a tremendous amount of hard work and expertise into resolving the issues at hand. I would also like to take this opportunity to inform you that we are greatly interested
Read More
Overall, the deliverable was well organized and my experience with the project team was good. In particular, I appreciated how they responded when I requested additional information and the Japanese version.
Read More
The IMARC team were extremely professional and very cooperative. The team were also extremely flexible in making changes and modifications wherever required. The entire experience right from project kick-off to after sales support was fruitful and smooth.
Read More
I’d like to express my gratitude for the work you accomplished with the industry report. The way you responded to the requirements and delivered under tight timelines shows your expertise, exceptional work ethic and commitment to your customer’s success. The entire team and company are incredibly thankful for your dedication. Once again, thank you
Read More
The market reports from IMARC have been instrumental in guiding our business strategies. We found the reports comprehensive and data-driven, which helped us make informed decisions. The detailed insights and actionable data have consistently provided us with a competitive edge in a rapidly changing alcohol market.
Read More
One of the best things about IMARC is their flexibility and predisposition to tailor the reports and adapt to our needs. They are not just great in their researching and consulting solutions, but their service is unparallelled. We’ve worked with them a couple of times and we will keep working with them in future projects.
Read More
We recently commissioned multiple market research reports from IMARC, and the insights we received were invaluable. The depth of analysis, accuracy of data, and actionable recommendations have greatly enhanced our strategic decision-making.
Read More
The market estimates provided by your team were pretty much in line with what we were theorizing internally. Really appreciate the work on this.
Read More
The sale account manager and the service was excellent. The data and market trends gathered from the report was insightful and really assisted while planning future product and growth strategies.
Read More
The report is excellent and has good amount of data and our team is extremely happy with the information provided.
Read More
Thank you very much for your cooperation and post purchase support. We were really happy with the final deliverable, and the takeaways from the report.
Read More